Horizon Discovery Group (HZD)
HZD Share PerformanceMore
|52 week high||188.05 29/04/16|
|52 week low||104.00 30/11/16|
|52 week change||-24.00 (-16.84%)|
|4 week volume||3,071,191 08/11/16|
Media for (HZD)
Latest News« previous» nextMore
02/12/2016 - 13:30 StockMarketWire
Dr Susan Galbraith, Non Executive Director, bought 40,000 shares in the company on the 2nd December 2016 at a price of...
02/12/2016 - 11:30 RNS
RNS Number: 8359Q Horizon Discovery Group plc 02 December 2016 Horizon Discovery Group plc Director/PDMR Shareholding Cambridge, UK, 2 December 2016: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or the "Company"), the world leader in the application of gene editing technologies , today announces that on 2 December 2016 Dr Susan Galbraith...
02/12/2016 - 10:00 RNS
RNS Number: 8194Q Horizon Discovery Group plc 02 December 2016 Horizon Discovery Group plc Director/PDMR Shareholding Cambridge, UK, 2 December 2016: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or the "Company"), the world leader in the application of gene editing technologies , today announces that certain directors of the Company purcha...
16/11/2016 - 07:30 StockMarketWire
Horizon Discovery Group has entered into partnerships with three leading Chinese diagnostic kit developers. Under the ter...
16/11/2016 - 07:00 RNS
RNS Number: 2032P Horizon Discovery Group plc 16 November 2016 Horizon Discovery Enters Chinese Clinical Diagnostics Market Three leading Chinese diagnostic kit manufacturers have initiated clinical trials using Horizon HDx Reference Standards Agreements provide upfront revenue with potential for strong recurring revenue streams post regulatory approv...
14/11/2016 - 07:00 RNS
RNS Number: 0218P Horizon Discovery Group plc 14 November 2016 14 November 2016 Horizon Discovery Group plc Additional Listing The Company has issued and allotted 5,554 new ordinary shares of 1p each pursuant to the exercise of options. Accordingly, an application has been made for 5,554 new ordinary shares to be admitted to trading on AIM and it is exp...
09/11/2016 - 07:29 StockMarketWire
Horizon Discovery has entered into an original equipment manufacturer (OEM) agreement with CareDx, a molecular dia...
09/11/2016 - 07:00 RNS
RNS Number: 6736O Horizon Discovery Group plc 09 November 2016 Horizon Discovery and CareDx Enter into OEM Agreement for Routine Inclusion of Cell-Free DNA Reference Standards in Transplant Testing Agreement builds on existing collaboration to develop cell-free DNA (cfDNA) Reference Standards to support CareDx's solid organ transplant injury m...
|Dividend yield||0 %|
Latest discussion posts More
“From Citywire: "?Biologic? era benefits Horizon Discovery, says Numis Gene-editing company Horizon Discovery (HZDH) has improved efficiency and is driving its product ...”▼
“"An announcement this morning sees Horizon expand the application of its bioproduction cell line platform with new partnerships with the Centre for Process Innovation (CPI, UK) ...”▼
“Following Horizon's announcement on 12th of May of a deal with an NGS Company, we are now given the name of the Company - QIAGEN N.V. a US$5bn NASDAQ and Frankfurt listed ...”▼
Codes & Symbols
|Symbols||HZD, LSE:HZD, HZD.L, HZD:LN, LON:HZD, XLON:HZD|